Wegovy Side Effects and How to Manage Them

Starting Wegovy often brings up questions — and side effects are usually top of the list. That is completely understandable. Knowing what is common, what is temporary, and how symptoms are typically managed can make treatment feel far more manageable and far less intimidating.

This guide covers what UK patients most commonly experience on Wegovy, with the actual incidence rates from the pivotal STEP-1 clinical trial, practical strategies for managing each side effect, the serious symptoms that warrant urgent medical attention, and how clinician-led care helps patients stay on treatment safely.

Why Side Effects Can Happen on Wegovy

Wegovy (semaglutide) is a GLP-1 receptor agonist. It works by mimicking glucagon-like peptide-1, a hormone that regulates appetite, fullness, and digestion. The mechanism produces three effects that explain the typical side effect profile:

• Slowed gastric emptying — food stays in the stomach longer, producing sustained fullness but also nausea and reflux in some patients
• Reduced appetite signalling — hunger signals weaken, which is the therapeutic goal but can also cause early fullness and reduced food intake that may contribute to fatigue
• Altered gut motility — changes in how the digestive tract moves food can produce constipation in some patients, diarrhoea in others

These mechanisms explain why most side effects are gastrointestinal, and why they tend to be most pronounced when the body first encounters the medication or steps up to a higher dose.

Wegovy always starts on a low 0.25mg dose and builds up gradually over 16 weeks for exactly this reason — the slower titration gives the body time to adapt. For the full dose progression: Wegovy dosages explained 0.25mg to 2.4mg.

Common Side Effects: Frequency and Detail

The table below shows side effect frequency from the pivotal STEP-1 trial (Wilding et al., NEJM 2021), which enrolled 1,961 adults with obesity over 68 weeks. These figures represent the proportion of patients on semaglutide 2.4mg who reported each side effect at any point during the study.

These rates compare against approximately 20% of patients on placebo reporting some gastrointestinal symptoms — so the medication does add to the baseline rate, but most effects are mild to moderate. Discontinuation due to gastrointestinal side effects in STEP-1 was around 4.5%.

Nausea: The Most Common Side Effect

Nausea is the side effect patients most often ask about. It affects approximately 44% of patients during treatment, but for most it is mild to moderate and improves as the body adapts.

When to expect it

• First 1-2 weeks after starting (the body adjusting to GLP-1 effects)
• The day or two after each weekly injection (peak drug concentration)
• After dose increases every 4 weeks during titration
• If eating too much, too quickly, or rich foods

Practical management strategies

• Eat smaller, more frequent meals — large portions trigger nausea most reliably
• Eat slowly and stop when comfortably satisfied — not when full
• Avoid rich, greasy, or spicy foods — these are slower to digest and worsen nausea
• Stay well hydrated — sip water throughout the day, particularly if appetite is reduced
• Keep meals simple in the first few weeks — bland foods like toast, rice, plain chicken, eggs are generally well tolerated
• Ginger — ginger tea or ginger biscuits help some patients
• Cold or room-temperature foods may be easier than hot meals when nausea is active
• Avoid lying down immediately after eating
• Stay upright for 30+ minutes after meals

Digestive Changes: Diarrhoea and Constipation

Wegovy affects gut motility, which means some patients experience diarrhoea (32% in trials) while others experience constipation (24%). Some patients experience both at different stages of treatment.

For diarrhoea

• Stay well hydrated — water, low-sugar electrolyte drinks
• Eat plain, easily digestible foods (rice, bananas, plain crackers, toast)
• Avoid alcohol, caffeine, and very fatty or spicy foods
• Reduce dairy temporarily if it seems to worsen symptoms
• Most cases settle within a few days; contact your prescriber if it persists more than a week

For constipation

• Increase fluid intake significantly — at least 1.5-2 litres per day
• Increase fibre gradually — vegetables, fruits with skin, wholegrains, beans, lentils
• Walk regularly — even gentle movement helps gut motility
• A daily fibre supplement (psyllium husk, ispaghula) can help
• Over-the-counter options like a stool softener or magnesium hydroxide are usually safe — check with your pharmacist

Feeling Full Quickly

Wegovy makes you feel full sooner than expected — sometimes after just a few bites. This is the intended therapeutic effect, but it takes adjustment.

Helpful strategies

• Use smaller plates and bowls — your eyes adjust to the appropriate portion size
• Eat mindfully rather than rushing — pay attention to fullness signals as they arrive
• Prioritise protein early in meals — this helps maintain muscle mass during weight loss and provides better satiety
• Don’t force meals — if you feel uncomfortably full, stop eating
• Eat little and often if needed — three smaller meals plus snacks works better than three large meals for many patients
• Stay hydrated separately from meals — drinking large amounts during meals fills your stomach further

Learning to trust new fullness signals takes time. This adjustment period is normal and is part of how the medication works long-term.

Fatigue, Headaches and Other Common Effects

Fatigue or low energy

Around 11% of patients in trials reported fatigue, particularly early on. This is often linked to reduced calorie intake, dehydration, or low blood sugar from skipping or reducing meals.

• Eat regularly, even if portions are smaller
• Include carbohydrates alongside protein — your brain needs glucose
• Stay well hydrated
• Choose gentle movement (walking) rather than intense exercise initially
• Prioritise sleep

Headaches

Headaches affect around 14% of patients. They are often linked to:

• Dehydration — drink more water
• Caffeine withdrawal if intake has decreased
• Low blood sugar from inadequate intake
• Adjustment to the medication itself in early weeks

Hair shedding

Some patients notice temporary increased hair shedding (telogen effluvium) several months into treatment. This is associated with significant weight loss generally, not Wegovy specifically. It typically resolves within 6 months and does not lead to permanent hair loss.

Injection site reactions

Around 3% of patients experience minor redness, itching, or a small bump at the injection site. These are almost always mild and resolve within a few days. Rotating injection sites helps.

For realistic timelines on progress: how fast you can lose weight on Wegovy.

Side Effects During Dose Increases

Wegovy follows a structured 16-week titration: 0.25mg → 0.5mg → 1mg → 1.7mg → 2.4mg, with each dose held for 4 weeks before increasing. It is common for mild side effects to briefly return when stepping up. This does not usually mean anything is wrong — it is part of the body adjusting to the higher dose.

Strategies for dose-increase weeks

• Plan the injection day for a weekend or quieter day if possible
• Eat lighter, plainer meals for the first 2-3 days after the increase
• Increase hydration deliberately
• Stick to the meal-management strategies that worked for you at the previous dose

Your prescriber may recommend:

• Staying on the same dose for longer than the standard 4 weeks
• Slowing dose progression (e.g. 6-week intervals rather than 4)
• Making small food or routine adjustments
• In some cases, returning to the previous dose for a few weeks before retrying

Support during dose changes makes a significant difference to comfort and treatment success. For the full dose schedule: Wegovy dosages guide.

Serious Side Effects to Watch For

Serious side effects on Wegovy are uncommon but it is important to recognise them. The following warrant prompt clinical assessment — most require stopping treatment and may need emergency care.

Slinic patients can also contact their prescribing pharmacist directly for clinical questions about whether what you are experiencing requires further assessment.

Who Should Not Take Wegovy

Wegovy is contraindicated (should not be used) in certain groups:

• Personal or family history of medullary thyroid carcinoma (MTC)
• Multiple Endocrine Neoplasia syndrome type 2 (MEN-2)
• Known hypersensitivity to semaglutide or any other ingredient
• Pregnancy or breastfeeding — Wegovy should be stopped at least 2 months before planning pregnancy
• Active eating disorders (anorexia, bulimia)
• Severe gastrointestinal disease including gastroparesis
• Type 1 diabetes (Wegovy is not licensed for this)

Wegovy requires caution and individualised assessment in patients with:

• History of pancreatitis
• Gallstones or gallbladder disease
• Severe kidney or liver disease
• Type 2 diabetes with retinopathy
• Patients taking other medications affected by delayed gastric emptying

A proper clinical consultation will assess all of these for you individually before prescribing.

When to Ask for Advice

While most side effects are manageable, it is important to seek guidance if:

• Symptoms feel persistent (more than 2-3 weeks at the same dose)
• Symptoms are worsening rather than improving
• Side effects interfere with daily life, work, or eating/hydration
• You are unsure whether what you are experiencing is expected
• You are considering stopping treatment
• You are due a dose increase but currently struggling with side effects

Early advice often prevents small issues becoming bigger concerns. Most side effect problems can be solved by adjusting timing, slowing titration, or making practical changes — but only if your prescriber knows about them.

Clinician-Led Support at Slinic

At Slinic, managing side effects is a core part of safe Wegovy treatment — not an afterthought. Our entire service is built around the practical reality that GLP-1 treatments require active clinical support, not just prescription and dispatch.

Shadeia Younis

Superintendent Pharmacist, Slinic (GPhC 2052119)

Every patient on Wegovy through Slinic has direct access to pharmacist-led clinical support throughout treatment, not just at consultation. Side effect questions, dose-change concerns, and tolerance issues are routine reasons to be in contact — they don’t need to wait for a scheduled review.

The goal is to keep treatment safe and tolerable, which often means slowing dose progression, adjusting timing, or simply confirming what you are experiencing is expected.

GPhC Registered Pharmacist GPhC No. 2052119 Superintendent Pharmacist, GPhC Pharmacy 1033729 Specialist in Weight Loss Treatment

Related Guides From Slinic

These guides go deeper on the topics most patients ask about alongside Wegovy side effects.

Frequently Asked Questions

Medical Disclaimer

This article provides educational information about Wegovy side effects in the UK and is not a substitute for professional medical advice. Wegovy (semaglutide) is a prescription-only medicine and should only be used together with a reduced-calorie diet and increased physical activity under appropriate clinical supervision. Always consult qualified healthcare providers about side effects and never discontinue treatment without clinical advice. Individual experience varies. Incidence rates quoted reflect clinical trial populations and may differ in real-world use.